- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 473/08 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
Patent holdings for IPC class C07D 473/08
Total number of patents in this class: 104
10-year publication summary
|
12
|
6
|
11
|
9
|
8
|
6
|
4
|
4
|
7
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Agency for Science, Technology and Research | 3563 |
11 |
| Eli Lilly and Company | 3715 |
4 |
| Syngenta Participations AG | 3033 |
3 |
| Cubist Pharmaceuticals, Inc. | 12 |
3 |
| Board of Regents, The University of Texas System | 5610 |
2 |
| Adenosine Therapeutics, LLC | 8 |
2 |
| Hydra Biosciences, Inc. | 42 |
2 |
| Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center | 149 |
2 |
| Pharmatrophix, Inc. | 22 |
2 |
| Theocorp Holding Company, LLC | 14 |
2 |
| Towa Pharmaceutical Co., Ltd. | 49 |
2 |
| The University of Tokyo | 4053 |
2 |
| West China Hospital, Sichuan University | 184 |
2 |
| Bioventures, LLC | 213 |
2 |
| Shanton Pharma Pte. Ltd. | 3 |
2 |
| Rhizen Pharmaceuticals AG | 56 |
2 |
| Merck Sharp & Dohme LLC | 3744 |
2 |
| Adovate, LLC | 3 |
2 |
| F. Hoffmann-La Roche AG | 7939 |
1 |
| The Regents of the University of California | 19493 |
1 |
| Other owners | 53 |